Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Conceptus, J&J/Gynecare Agreement Will Aid Essure Adoption – CEO

This article was originally published in The Gray Sheet

Executive Summary

Conceptus will target physicians comfortable with new technology adoption through a co-promotional agreement with Johnson & Johnson/Gynecare

You may also be interested in...



AMS May Enter Permanent Birth-Control Market Via Merger Or License

Conceptus has less than three weeks to decide whether to purchase Ovion or to allow the transcervical sterilization device developer to merge with American Medical Systems

AMS May Enter Permanent Birth-Control Market Via Merger Or License

Conceptus has less than three weeks to decide whether to purchase Ovion or to allow the transcervical sterilization device developer to merge with American Medical Systems

Adiana Readying To Compete With Conceptus In Contraceptive Market

Adiana plans to file a PMA for its non-incisional permanent birth control procedure next December, approximately three years after Conceptus received approval for its Essure device

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT019498

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel